Antibacterial Activity of Functionalized Dihydropyrimidines
申请人:WiSys Technology Foundation, Inc.
公开号:US20220220082A1
公开(公告)日:2022-07-14
Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant
S. aureus
growth. One such compound is: